High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23

Objective: Iron isomaltoside (Monofer(®)) is a high-dose intravenous iron preparation with good tolerability and efficacy in inflammatory bowel disease (IBD) patients with iron deficiency anaemia (IDA). This trial evaluates the safety and efficacy, including effect on intact fibroblast growth factor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Scand J Gastroenterol
Principais autores: Dahlerup, Jens Frederik, Jacobsen, Bent A., van der Woude, Janneke, Bark, Lars-Åke, Thomsen, Lars L., Lindgren, Stefan
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5152597/
https://ncbi.nlm.nih.gov/pubmed/27326766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/00365521.2016.1196496
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados